Andrea Pacesova

Prague, PR 16610, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Integrative role of orexigenic peptides in neuroprotection and neurodegenerative disease modulation.

Integrative role of orexigenic peptides in neuroprotection and neurodegenerative disease modulation.

Journal: Bioscience reports

Published: December 15, 2025

Neuroprotective potential of novel CARTp analogs in the hippocampus of THY-Tau22 mouse model of Tau pathology.

Neuroprotective potential of novel CARTp analogs in the hippocampus of THY-Tau22 mouse model of Tau pathology.

Journal: Neuropharmacology

Published: March 28, 2025

Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease.

Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease.

Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

Published: October 13, 2024

Deficiency of GPR10 and NPFFR2 receptors leads to sex-specific prediabetic syndrome and late-onset obesity in mice.

Deficiency of GPR10 and NPFFR2 receptors leads to sex-specific prediabetic syndrome and late-onset obesity in mice.

Journal: Bioscience reports

Published: September 06, 2024

Lipidized analogues of the anorexigenic CART (cocaine- and amphetamine-regulated transcript) neuropeptide show anorexigenic and neuroprotective potential in mouse model of monosodium-glutamate induced obesity.

Lipidized analogues of the anorexigenic CART (cocaine- and amphetamine-regulated transcript) neuropeptide show anorexigenic and neuroprotective potential in mouse model of monosodium-glutamate induced obesity.

Journal: European journal of pharmacology

Published: April 30, 2024

Anorexigenic neuropeptides as anti-obesity and neuroprotective agents: exploring the neuroprotective effects of anorexigenic neuropeptides.

Anorexigenic neuropeptides as anti-obesity and neuroprotective agents: exploring the neuroprotective effects of anorexigenic neuropeptides.

Journal: Bioscience reports

Published: January 31, 2024

Feeding High-Fat Diet Accelerates Development of Peripheral and Central Insulin Resistance and Inflammation and Worsens AD-like Pathology in APP/PS1 Mice.

Feeding High-Fat Diet Accelerates Development of Peripheral and Central Insulin Resistance and Inflammation and Worsens AD-like Pathology in APP/PS1 Mice.

Journal: Nutrients

Published: July 13, 2023

GPR160 is not a receptor of anorexigenic cocaine- and amphetamine-regulated transcript peptide.

GPR160 is not a receptor of anorexigenic cocaine- and amphetamine-regulated transcript peptide.

Journal: European journal of pharmacology

Published: December 18, 2022

Age-related metabolic and neurodegenerative changes in SAMP8 mice.

Age-related metabolic and neurodegenerative changes in SAMP8 mice.

Journal: Aging

Published: February 05, 2022

Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances.

Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances.

Journal: Nutrition & diabetes

Published: July 23, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026